Evidence map›Paper›PMID 31281193›Full record

ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2019

Canadian dog owners' use and perceptions of cannabis products.

Lori R Kogan, Peter W Hellyer, Sarah Silcox, Regina Schoenfeld-Tacher

Open access · greenAbstract read
In one paragraph

Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Canine immune cells express high levels of CBVeterinary immunology and immunopathology · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lori R KoganDepartment of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, USA (Kogan, Hellyer); Canadian Association of Veterinary Cannabinoid Medicine, Ajax, Ontario L1Z 0B6 (Silcox); North Carolina State University - College of Veterinary Medicine, Raleigh, North Carolina, USA (Schoenfeld-Tacher).
Peter W HellyerDepartment of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, USA (Kogan, Hellyer); Canadian Association of Veterinary Cannabinoid Medicine, Ajax, Ontario L1Z 0B6 (Silcox); North Carolina State University - College of Veterinary Medicine, Raleigh, North Carolina, USA (Schoenfeld-Tacher).
Sarah SilcoxDepartment of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, USA (Kogan, Hellyer); Canadian Association of Veterinary Cannabinoid Medicine, Ajax, Ontario L1Z 0B6 (Silcox); North Carolina State University - College of Veterinary Medicine, Raleigh, North Carolina, USA (Schoenfeld-Tacher).
Regina Schoenfeld-TacherDepartment of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, USA (Kogan, Hellyer); Canadian Association of Veterinary Cannabinoid Medicine, Ajax, Ontario L1Z 0B6 (Silcox); North Carolina State University - College of Veterinary Medicine, Raleigh, North Carolina, USA (Schoenfeld-Tacher).
Colorado State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The legal market for recreational and medicinal cannabis for human consumption is growing worldwide. At the same time, marketing of cannabis products for use in pets is expanding. Yet, there is little research exploring the effects of cannabis use in veterinary medicine. This study used an anonymous, online survey to assess Canadian pet owners' reasons for purchasing cannabis products for their dogs, and their perceptions regarding efficacy of these treatments. Owners purchased cannabis products for treatment of pain, inflammation, and anxiety in dogs, and perceived these preparations to be equally or more effective than conventional medications. Most owners reported only minimal side effects in their dogs. Despite indicating comfort in discussing canine cannabis administration with their veterinarian, most owners relied on commercial websites for product information. The main reasons for choosing cannabis products were the ability to use as an adjuvant to other therapies, and the perception of it being a natural substance. Given this information, it is incumbent upon veterinarians to appropriately counsel their clients, and also to advocate for evidence-based studies to evaluate the efficacy of cannabis use in non-human species.

Indexed as

CannabisVeterinariansAnimalsCanadaDogsHumansOwnershipPetsSurveys and Questionnaires

Identifiers

PMID31281193
PMCPMC6563876
OpenAlexW2989804886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.